A Phase I Study of Epitinib(HMPL-813) in Patients With Advanced Solid Tumors

NCT02590952 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
108
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Hutchison Medipharma Limited